Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

354 recalls, newest first

Class II · Moderate risk

Ful-Glo

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

Ongoing Impurity / degradation Nomax Inc NDC 17478-404-01 D-0465-2024
Class II · Moderate risk

Ful-Glo

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

Ongoing Impurity / degradation Nomax Inc NDC 17478-403-03 D-0464-2024
Class II · Moderate risk

GloStrips

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

Ongoing Impurity / degradation Nomax Inc NDC 51801-009-40 D-0463-2024
Class II · Moderate risk

GloStrips

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

Ongoing Impurity / degradation Nomax Inc NDC 51801-003-40 D-0462-2024
Class II · Moderate risk

Aloe Gator

Out of Specification for active ingredient

Ongoing Failed specification ARG Laboratories, Inc. D-0530-2024
Class II · Moderate risk

Natural Pain Relieving Cream

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0529-2024
Class II · Moderate risk

Pain Wizard

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0528-2024
Class II · Moderate risk

Natural Pain Relieving Cream

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0527-2024
Class II · Moderate risk

Natural Pain Relieving Cream

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0526-2024
Class II · Moderate risk

Pain Wizard

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0525-2024
Class II · Moderate risk

Pain Wizard

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0524-2024
Class II · Moderate risk

Aloe Gator

Out of Specification for active ingredient

Ongoing Failed specification ARG Laboratories, Inc. D-0523-2024
Class II · Moderate risk

Natural Pain Relieving Cream

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0521-2024
Class II · Moderate risk

Pain Wizard

Out of Specification for active ingredient. Violative grade of propylene glycol used during the manufacturing process.

Ongoing Failed specification ARG Laboratories, Inc. D-0520-2024
Class III · Low risk

Abilify (aripiprazole)

Cross Contamination with Other Products

Ongoing Cross-contamination Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. NDC 59148-011-13 D-0469-2024

Recalls by year